Cargando…
CFTR reduces the proliferation of lung adenocarcinoma and is a strong predictor of survival in both smokers and non-smokers
BACKGROUND: One of the main hurdles of oncological therapy is the development of drug resistance. The ABC transporter gene family contributes majorly to cancer chemoresistance. However, effects of somatic expression of most ABC transporters on cancer outcomes remain largely unclear. METHODS: We syst...
Autores principales: | Xiao, Qingyang, Koutsilieri, Stefania, Sismanoglou, Despoina-Christina, Lauschke, Volker M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587080/ https://www.ncbi.nlm.nih.gov/pubmed/35715537 http://dx.doi.org/10.1007/s00432-022-04106-x |
Ejemplares similares
-
Characteristics of genomic alterations of lung adenocarcinoma in young never‐smokers
por: Luo, Wenxin, et al.
Publicado: (2018) -
Gene expression subtraction of non-cancerous lung from smokers and non-smokers with adenocarcinoma, as a predictor for smokers developing lung cancer
por: Stav, David, et al.
Publicado: (2008) -
Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokers
por: Luo, Wenxin, et al.
Publicado: (2023) -
Predictors of COPD in symptomatic smokers and ex-smokers seen in primary care
por: Tupper, Oliver Djurhuus, et al.
Publicado: (2018) -
Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma
por: Mack, Philip C, et al.
Publicado: (2022)